STRASBOURG, France--(BUSINESS WIRE)--Regulatory News:
Transgene’s (Paris:TNG) shareholders held their Combined General Meeting (ordinary and extraordinary) today, chaired by Philippe Archinard, Chairman and CEO, to approve the company financial statements for the year ended December 31, 2017 and to vote on the other resolutions submitted to their approval.
At the Combined General Meeting, the shareholders have voted the resolutions submitted, in accordance with the recommendations of the Board of Directors.
